Sign in

CIK 0001980845 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

enGene Therapeutics Inc.

Sign in to watch
Ticker
ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Oct 31
Incorporated
Canada (Federal Level)
Entity type
operating
Phone
(514) 332-4888
Business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
Former names
enGene Holdings Inc.

Securities

  • ENGN Common Stock Nasdaq
  • ENGNW Warrants Nasdaq
  1. 8-K Event Results of operations · Regulation FD disclosure · Other events
  2. 8-K Event Results of operations
  3. 8-K Event Other events
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Executive or director change · Regulation FD disclosure
  6. 8-K/A Event Exit or restructuring costs · Executive or director change
  7. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Regulation FD disclosure · Other events
  8. 8-K Event Shareholder vote results
  9. 8-K Event Executive or director change · Regulation FD disclosure · Other events
  10. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  11. 8-K Event Material agreement · Agreement ended
  12. 8-K Event Results of operations
  13. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Results of operations
  16. 8-K Event Material agreement · Regulation FD disclosure
  17. 8-K Event Regulation FD disclosure · Other events
  18. 8-K Event Executive or director change
  19. 8-K/A Event Executive or director change
  20. 8-K Event Regulation FD disclosure

Page 1 of 3 · 52 filings